Cargando…

Targeting of Androgen Receptor Expression by Andro-miRs as Novel Adjunctive Therapeutics in Prostate Cancer

Prostate cancer begins as an androgen-responsive disease. However, subsequent accumulation of multiple sequential genetic and epigenetic alterations transforms the disease into an aggressive, castration-resistant prostate cancer (CRPC). The monoallelic Androgen Receptor (AR) is associated with the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebron, Jey Sabith, Weyman, Crystal M., Shukla, Girish C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751888/
https://www.ncbi.nlm.nih.gov/pubmed/26877888
http://dx.doi.org/10.4236/jct.2013.44A006

Ejemplares similares